Printer Friendly

Browse Employee stock options topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
CVW Cleantech announces upsize of private placement, grant of stock options. Sep 20, 2022 303
BioCryst reports inducement grants under Nasdaq listing rule. Sep 6, 2022 170
Lexagene Holdings announces filing of financial statements, revocation of MCTO. Jul 29, 2022 279
Osisko Development announces annual grant of stock options. Jul 1, 2022 184
Arcturus Therapeutics grants stock options to four new employee as part of Nasdaq Listing Rule 5635(c)(4). Apr 25, 2022 197
Arcturus Therapeutics grants stock options to four new employee as part of Nasdaq Listing Rule 5635(c)(4). Apr 25, 2022 196
Marinus grants non-qualified stock option to new employee as part of Nasdaq Listing Rule 5635(C)(4). Apr 19, 2022 174
Marinus grants non-qualified stock option to new employee as part of Nasdaq Listing Rule 5635(C)(4). Apr 19, 2022 175
Milestone Pharmaceutical's Compensation Committee grants incentive stock options. Apr 18, 2022 209
Milestone Pharmaceutical's Compensation Committee grants incentive stock options. Apr 18, 2022 210
Airgain Inc reports grant of stock option & restricted stock units to nine new non-executive employees as part of Nasdaq Listing Rule 5635(c)(4). Apr 18, 2022 236
Mirum grants stock options and restricted RSUs to five new employees under Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 206
Ligand Pharmaceuticals grants non-qualified stock option to CFO of its antibody discovery business, Kurt Gustafson. Apr 11, 2022 177
Infinity Pharmaceuticals reports inducement grants to two non-statutory stock options as part of Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 191
Biocept reports grant of stock options at USD2.32 per share as part of Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 205
Mirum grants stock options and restricted RSUs to five new employees under Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 207
Ligand Pharmaceuticals grants non-qualified stock option to CFO of its antibody discovery business, Kurt Gustafson. Apr 11, 2022 178
Infinity Pharmaceuticals reports inducement grants to two non-statutory stock options as part of Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 192
Biocept reports grant of stock options at USD2.32 per share as part of Nasdaq Listing Rule 5635(c)(4). Apr 11, 2022 204
Verastem grants stock options as well as restricted stock units under Nasdaq Listing Rule 5635(c)(4). Apr 5, 2022 207
Verastem grants stock options as well as restricted stock units under Nasdaq Listing Rule 5635(c)(4). Apr 5, 2022 208
ImmunoGen reports stock options award to three new employees. Apr 4, 2022 173
Adicet Bio grants 36,000 non-qualified stock options to two new employees. Apr 4, 2022 196
MEI Pharma awards stock options to four new employees. Apr 4, 2022 166
Arcturus Therapeutics grants stock option to two new employees as part of Nasdaq Listing Rule 5635(c)(4). Mar 21, 2022 194
Geron grants non-statutory stock options to new employees. Mar 18, 2022 158
Marinus Pharmaceuticals grants inducement stock options to three new employees. Mar 16, 2022 182
Ardelyx Inc reports grant of stock options & RSUs under Nasdaq Listing Rule 5635(c)(4). Mar 10, 2022 214
Ardelyx Inc reports grant of stock options & RSUs under Nasdaq Listing Rule 5635(c)(4). Mar 10, 2022 215
Iveric Bio awards non-statutory stock options and restricted stock units as part of Nasdaq Listing Rule 5635(c)(4). Awards list Mar 3, 2022 210
GlycoMimetics awards stock options to new executive. Feb 24, 2022 217
GlycoMimetics awards stock options to new executive. Feb 24, 2022 216
Sierra grants stock option at exercise price of USD30.85 per share under NASDAQ Listing Rule 5635(c)(4). Feb 21, 2022 173
Sierra grants stock option at exercise price of USD30.85 per share under NASDAQ Listing Rule 5635(c)(4). Feb 21, 2022 174
Athersys reports grant of stock option to new CEO Daniel Camardo. Feb 18, 2022 257
SchrA[pilcrow sign]dinger awards stock options to 17 new employees. Feb 18, 2022 286
Marinus grants stock options & restricted stock units to six new employees. Feb 11, 2022 216
KalVista grants inducement stock options to four new employees. Feb 3, 2022 174
ImmunoGen grants stock options to four new employees pursuant to Nasdaq Listing Rule 5635(c)(4). Feb 2, 2022 184
SchrA[pilcrow sign]dinger grants non-statutory stock options to 80 new employees as part of Nasdaq Listing Rule 5635(c)(4). Jan 21, 2022 243
SchrA[pilcrow sign]dinger grants non-statutory stock options to 80 new employees as part of Nasdaq Listing Rule 5635(c)(4). Jan 21, 2022 241
Geron announces 435,800 common stock options pursuant to Nasdaq Listing Rule 5635(c)(4). Jan 21, 2022 202
SchrA[pilcrow sign]dinger grants non-statutory stock options to 80 new employees as part of Nasdaq Listing Rule 5635(c)(4). Jan 21, 2022 240
Geron announces 435,800 common stock options pursuant to Nasdaq Listing Rule 5635(c)(4). Jan 21, 2022 201
Airgain grants stock options & RSUs to non-executive vice president, Global Operations Victor Blair under Nasdaq Rule 5635(c)(4). Jan 19, 2022 210
Marinus Pharmaceuticals grants stock options to five new employees under Nasdaq Listing Rule 5635(C)(4). Jan 17, 2022 224
Marinus Pharmaceuticals grants stock options to five new employees under Nasdaq Listing Rule 5635(C)(4). Jan 17, 2022 225
Senseonics reports stock options at exercise price of USD2.68 per share. Jan 6, 2022 164
Iveric Bio announces non-statutory stock options to eight new employees under Nasdaq Listing Rule 5635(c)(4). Jan 5, 2022 214
Iveric Bio announces non-statutory stock options to eight new employees under Nasdaq Listing Rule 5635(c)(4). Jan 5, 2022 213
GreenPower Motor Company grants stock options. Dec 13, 2021 224
AVROBIO grants inducement non-statutory stock options to two new employees under Nasdaq Listing Rule 5635(c)(4). Dec 8, 2021 190
AVROBIO grants inducement non-statutory stock options to two new employees under Nasdaq Listing Rule 5635(c)(4). Dec 8, 2021 189
Luminex grants stock options at exercise price of CAD0.51 per share. Nov 26, 2021 196
Marinus Pharmaceuticals grants stock options to five new employees under Nasdaq Listing Rule 5635(c)(4). Nov 9, 2021 185
Marinus Pharmaceuticals grants stock options to five new employees under Nasdaq Listing Rule 5635(c)(4). Nov 9, 2021 184
Epizyme reports grant of stock options under Nasdaq Listing Rule 5635(c)(4). Nov 8, 2021 179
Dynavax announces stock options at exercise price of USD17.14 per share under Nasdaq Listing Rule 5635(c)(4). Oct 19, 2021 177
Dynavax announces stock options at exercise price of USD17.14 per share under Nasdaq Listing Rule 5635(c)(4). Oct 19, 2021 178
Marinus Pharmaceuticals grants stock options to five new employees under Nasdaq Listing Rule 5635(c)(4). Oct 11, 2021 174
AVROBIO grants stock options at exercise price of USD5.64 per share. Oct 6, 2021 197
AVROBIO grants stock options at exercise price of USD5.64 per share. Oct 6, 2021 196
Sierra Oncology grants stock options to two new employees under NASDAQ Listing Rule 5635(c)(4). Oct 5, 2021 183
Senseonics grants 11 new non-executive employees with non-qualified stock options under NYSE American Company Guide Section 711(a). Oct 5, 2021 180
Sierra Oncology grants stock options to two new employees under NASDAQ Listing Rule 5635(c)(4). Oct 5, 2021 184
Atara announces grant of restricted stock units and stock options under Nasdaq Listing Rule 5635(C)(4). Oct 4, 2021 233
Dicerna announces RSUs & common stock options pursuant to Nasdaq Listing Rule 5635(c)(4). Oct 4, 2021 213
ImmunoGen grants stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Oct 4, 2021 189
Atara announces grant of restricted stock units and stock options under Nasdaq Listing Rule 5635(C)(4). Oct 4, 2021 232
Dicerna announces RSUs & common stock options pursuant to Nasdaq Listing Rule 5635(c)(4). Oct 4, 2021 212
ImmunoGen grants stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Oct 4, 2021 188
Arena Pharmaceuticals grants stock options and restricted stock units under Nasdaq Listing Rule 5635(c)(4). Sep 20, 2021 235
Marinus Pharmaceuticals grants inducement stock options to five new employees. Sep 10, 2021 154
Magna Gold reports grant of stock option at exercise price of CAD0.90 per common share. Sep 6, 2021 151
Blueprint Medicines grants stock options & RSUs as part of NASDAQ Listing Rule 5635(c)(4). Sep 6, 2021 209
Insmed grants stock options to 18 new employees pursuant to NASDAQ Listing Rule 5635(c)(4). Sep 6, 2021 185
Insmed grants stock options to 18 new employees pursuant to NASDAQ Listing Rule 5635(c)(4). Sep 6, 2021 184
Biocept grants common stock options to 16 new employees. Sep 1, 2021 171
Nabriva Therapeutics reports inducement grants under Nasdaq listing rule. Sep 1, 2021 187
Geron awards stock options to new employees. Aug 20, 2021 157
bluebird bio Inc grants stock options & RSUs as part of Nasdaq Listing Rule 5635(c)(4). Aug 5, 2021 207
AVROBIO announces stock options to five new employees as part of Nasdaq Listing Rule 5635(c)(4). Aug 5, 2021 180
bluebird bio Inc grants stock options & RSUs as part of Nasdaq Listing Rule 5635(c)(4). Aug 5, 2021 208
AVROBIO announces stock options to five new employees as part of Nasdaq Listing Rule 5635(c)(4). Aug 5, 2021 179
Atara Biotherapeutics grants restricted stock units plus stock options under Nasdaq Listing Rule 5635(c)(4). Aug 3, 2021 227
Atara Biotherapeutics grants restricted stock units plus stock options under Nasdaq Listing Rule 5635(c)(4). Aug 3, 2021 226
Arena grants inducement stock options and RSUs to new employees. Jul 26, 2021 230
Geron awards stock options to new employees. Jul 23, 2021 173
Curis awards stock options to 15 new employees. Jul 8, 2021 175
ImmunoGen awards non-qualified stock options to new employees. Jul 2, 2021 167
Dicerna grants stock options and RSUs to new employee. Jul 2, 2021 180
Bitfarms announces grant of options, RSUs. Jun 30, 2021 189
K bank to grant stock option for every employee. Jun 25, 2021 328
Arena Pharmaceuticals' board approves stock options & RSUs pursuant to Nasdaq Listing Rule 5635(c)(4). Jun 21, 2021 232
Arena Pharmaceuticals' board approves stock options & RSUs pursuant to Nasdaq Listing Rule 5635(c)(4). Jun 21, 2021 233
SchrA[pilcrow sign]dinger announces grant of stock options to 14 new employees under Nasdaq Listing Rule 5635(c)(4). Jun 18, 2021 200
SchrA[pilcrow sign]dinger announces grant of stock options to 14 new employees under Nasdaq Listing Rule 5635(c)(4). Jun 18, 2021 199
SchrA[pilcrow sign]dinger announces grant of stock options to 14 new employees under Nasdaq Listing Rule 5635(c)(4). Jun 18, 2021 202
Atara Biotherapeutics grants restricted stock units and stock options pursuant to Nasdaq Listing Rule 5635(C)(4). Jun 7, 2021 233
Atara Biotherapeutics grants restricted stock units and stock options pursuant to Nasdaq Listing Rule 5635(C)(4). Jun 7, 2021 232
bluebird bio Inc grants stock options and RSUs to new CCO. Jun 3, 2021 208
Nabriva Therapeutics reports inducement grants under Nasdaq listing rule. Jun 1, 2021 187
Uranium Royalty Corp announces award of incentive stock options and digital marketing agreement with Wallace Hill. Jun 1, 2021 196
CymaBay announces inducement grant under Nasdaq listing rule. May 18, 2021 178
Atara Biotherapeutics' board announces restricted stock units & stock options pursuant to Nasdaq Listing Rule 5635(C)(4). May 17, 2021 213
Atara Biotherapeutics' board announces restricted stock units & stock options pursuant to Nasdaq Listing Rule 5635(C)(4). May 17, 2021 214
Mirum Pharmaceuticals awards stock options to nine new employees under Nasdaq Listing Rule 5635(c)(4). Awards list May 11, 2021 161
Mirum Pharmaceuticals awards stock options to nine new employees under Nasdaq Listing Rule 5635(c)(4). Awards list May 11, 2021 162
AVROBIO Inc announces non-statutory stock options to five new employees under Nasdaq Listing Rule 5635(c)(4). May 7, 2021 196
Iveric Bio announces stock options to four new non-executive as part of the Nasdaq Listing Rule 5635(c)(4). May 5, 2021 231
ImmunoGen announces stock options to four employees as part of Nasdaq Listing Rule 5635(c)(4). May 4, 2021 200
ImmunoGen announces stock options to four employees as part of Nasdaq Listing Rule 5635(c)(4). May 4, 2021 201
Geron grants stock options to new employees. Apr 23, 2021 176
Arena Pharmaceuticals awards stock options and restricted stock units to new employees. Apr 19, 2021 219
Sesen Bio reports grant of non-statutory stock options to four new employees. Apr 19, 2021 221
SchrA[pilcrow sign]dinger grants non-statutory stock options to three new employees. Apr 19, 2021 163
Mirum Pharmaceuticals announces stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4). Apr 13, 2021 166
SECP enables startups to offer Employee Stock Options Plan. Apr 8, 2021 168
SECP enables startups to offer employee stock options plan. Apr 8, 2021 230
SECP enables Startups to offer Employee Stock Options Plan. Apr 8, 2021 237
AVROBIO grants non-statutory stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4). Apr 7, 2021 178
AVROBIO grants non-statutory stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4). Apr 7, 2021 179
Recro Pharma reports inducement grants for new staff. Apr 6, 2021 170
Marinus Pharmaceuticals Inc awarded non-qualified inducement stock options to 12 new employees under Nasdaq Listing Rule 5635(c)(4). Mar 25, 2021 222
Arcus Biosciences' board reports stock options at exercise price per share of USD34.45. Mar 25, 2021 163
Marinus Pharmaceuticals Inc awarded non-qualified inducement stock options to 12 new employees under Nasdaq Listing Rule 5635(c)(4). Mar 25, 2021 221
Arcus Biosciences' board reports stock options at exercise price per share of USD34.45. Mar 25, 2021 162
Sesen Bio reports stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Mar 23, 2021 219
Sesen Bio reports stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Mar 23, 2021 220
Geron announces stock options at exercise price of USD1.81 per share under Nasdaq Listing Rule 5635(c)(4). Mar 19, 2021 199
Kala Pharmaceuticals reports stock options to four new employees under NASDAQ Listing Rule 5635(c)(4). Mar 19, 2021 171
Kala Pharmaceuticals reports stock options to four new employees under NASDAQ Listing Rule 5635(c)(4). Mar 19, 2021 170
Mirum Pharmaceuticals grants stock options to five new employees pursuant to Nasdaq Listing Rule 5635(c)(4). Mar 11, 2021 167
Atara Biotherapeutics announces grant of restricted stock units and stock options under Nasdaq Listing Rule 5635(C)(4). Mar 8, 2021 245
Atara Biotherapeutics announces grant of restricted stock units and stock options under Nasdaq Listing Rule 5635(C)(4). Mar 8, 2021 246
Biocept grants stock options to six new employees under Nasdaq Listing Rule 5635(c)(4). Mar 4, 2021 172
Biocept grants stock options to six new employees under Nasdaq Listing Rule 5635(c)(4). Mar 4, 2021 173
Marinus Pharmaceuticals grants 72,500 common stock to new employees under Nasdaq Listing Rule 5635(c)(4). Feb 15, 2021 263
Biocept announces stock options to five new employees pursuant to Nasdaq Listing Rule 5635(c)(4). Feb 3, 2021 208
Arena Pharmaceuticals grants five new employees inducement stock options and restricted stock units. Jan 25, 2021 292
Arcus Biosciences reports grant of stock options to three new employees. Jan 13, 2021 153
Arcus Biosciences reports grant of stock options to three new employees. Jan 13, 2021 157
AVROBIO grants stock options to three new employees. Jan 8, 2021 183
Blueprint Medicines grants stock option & RSUs under NASDAQ Listing Rule 5635(c)(4). Jan 6, 2021 244
Blueprint Medicines grants stock option & RSUs under NASDAQ Listing Rule 5635(c)(4). Jan 6, 2021 240
Kala Pharmaceuticals announces non-statutory stock options to 46 new employees. Dec 21, 2020 190
ESO Fund helps employees exercise stock options with ESO Venture Fund IV. Dec 11, 2020 225
ESO Fund helps employees exercise stock options with ESO Venture Fund IV. Dec 11, 2020 223
Marinus announces non-qualified stock options to two new employees under Nasdaq Listing Rule 5635(c)(4). Dec 7, 2020 206
AVROBIO grants stock option to new employee under Nasdaq Listing Rule 5635(c)(4). Dec 7, 2020 179
Marinus announces non-qualified stock options to two new employees under Nasdaq Listing Rule 5635(c)(4). Dec 7, 2020 210
AVROBIO grants stock option to new employee under Nasdaq Listing Rule 5635(c)(4). Dec 7, 2020 183
Dicerna authorises stock options and restricted stock units (RSUs) under Nasdaq listing Rule 5635(c)(4). Dec 2, 2020 231
Does Executive Compensation Restrict Firm Over-investment? Elseoud, Mohamed Sayed Abou; Ebrahim, Rabab; Mili, Mehdi; Yassin, Mohamed Dec 1, 2020 4922
Luminex grants incentive stock options for 1.2m common shares. Nov 27, 2020 297
Kala Pharmaceuticals grants stock options to new employees. Nov 19, 2020 172
Dicerna awards stock options and RSUs under Nasdaq Listing Rule 5635(c)(4). Awards list Nov 3, 2020 226
ImmunoGen grants non-qualified stock option award to new employee under Nasdaq Listing Rule 5635(c)(4). Nov 3, 2020 197
Xeris Pharmaceuticals grants stock options to 15 new employees under NASDAQ Listing Rule 5635(c)(4). Nov 2, 2020 203
Kala Pharmaceuticals announces grant of stock options under NASDAQ Listing Rule 5635(c)(4). Oct 20, 2020 189
Marinus Pharmaceuticals awards stock options to 11 new employees. Oct 15, 2020 214
Geron grants new employee stock option at exercise price of USD1.81 per share. Sep 18, 2020 177
ABL Bio retains workers via strong employee stock option plan. Sep 11, 2020 441
GlycoMimetics awards stock options to three new employees. Sep 7, 2020 178
NA Proactive news snapshot:AaExro Technologies, Silver Range Resources, ElectraMeccanica Vehicles, Humanigen, Canada Silver Cobalt Works, Co-Diagnostics UPDATE ... Sep 2, 2020 3891
Xeris Pharmaceuticals reports grant to stock options to a new employee under NASDAQ Listing Rule 5635(c)(4). Aug 31, 2020 188
Geron grants non-statutory stock options to four new employees. Aug 21, 2020 176
Marinus reports grant of stock options to seven new employees under Nasdaq Listing Rule 5635(c)(4). Aug 12, 2020 202
Marinus reports grant of stock options to seven new employees under Nasdaq Listing Rule 5635(c)(4). Aug 12, 2020 206
AVROBIO announces non-statutory stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Aug 10, 2020 189
AVROBIO announces non-statutory stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Aug 10, 2020 193
ImmunoGen reports grant to stock option to new employee under Nasdaq Listing Rule 5635(c)(4). Aug 4, 2020 190
ImmunoGen reports grant to stock option to new employee under Nasdaq Listing Rule 5635(c)(4). Aug 4, 2020 186
Why employee stock option schemes are unpopular. Dilawar Hussain Aug 4, 2020 971
Novavax execs could get big payday even if vaccine fails. Reuters News Service Jul 22, 2020 1101
Kala Pharmaceuticals grants stock options to new employees. Jul 20, 2020 171
Personalis awards non-qualified stock options and RSUs to seven new employees. Jul 17, 2020 205
AVROBIO awards non-statutory stock options to five new employees. Jul 9, 2020 194
Dicerna grants stock options and RSUs to 15 new employees under Nasdaq listing Rule 5635(c)(4). Jul 2, 2020 238
EnWave announces equity incentive grants. Jun 19, 2020 292
Personalis awards stock options and RSUs to 12 new employees as part of NASDAQ Listing Rule 5635(c)(4). Awards list Jun 17, 2020 237
Ardelyx grants stock option and restricted stock to new CFO Justin Renz in accordance with Nasdaq Listing Rule 5635(c)(4). Jun 10, 2020 207
Akebia Therapeutics announces grant of stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Jun 3, 2020 158
Arena announces inducement stock options and restricted stock units to new employees. May 21, 2020 248
PTC Therapeutics announces grant of non-statutory stock options plus restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4). May 18, 2020 286
Theratechnologies announces inducement grants under Nasdaq listing rule. Apr 16, 2020 169
Curis grants stock options to three new employees pursuant to NASDAQ Listing Rule 5635(c)(4). Apr 6, 2020 225
Curis grants stock options to three new employees pursuant to NASDAQ Listing Rule 5635(c)(4). Apr 6, 2020 221
Randolph Bancorp grants inducement awards. Apr 2, 2020 161
Acasti Pharma announces annual stock option grants. Apr 1, 2020 207
PTC Therapeutics grants non-statutory stock options to new employees under NASDAQ Listing Rule 5635(c)(4). Mar 12, 2020 211
Sage Therapeutics reports grant of common stock options and performance restricted stock units to new employee. Mar 5, 2020 217
Xeris Pharmaceuticals grants non-qualified stock options to new employee under NASDAQ Listing Rule 5635(c)(4). Mar 2, 2020 188
Xeris Pharmaceuticals grants non-qualified stock options to new employee under NASDAQ Listing Rule 5635(c)(4). Mar 2, 2020 184
Sage Therapeutics reports grant of common stock options and PSUs to four new employees. Feb 5, 2020 230
Sage Therapeutics reports grant of common stock options and PSUs to four new employees. Feb 5, 2020 226
Dicerna grants stock options and restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4). Feb 4, 2020 265
Athersys grants inducement stock option to new CFO Ivor Macleod. Feb 4, 2020 202
Dicerna grants stock options and restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4). Feb 4, 2020 261
Athersys grants inducement stock option to new CFO Ivor Macleod. Feb 4, 2020 198
Sesen Bio grants non-statutory stock options to three new employees under Nasdaq Listing Rule 5635(c)(4). Feb 3, 2020 197
Xeris Pharmaceuticals grants stock options to three new employees under NASDAQ Listing Rule 5635(c)(4). Feb 3, 2020 194
Xeris Pharmaceuticals grants stock options to three new employees under NASDAQ Listing Rule 5635(c)(4). Feb 3, 2020 190
Deer Horn Announces Increase to Non-Brokered Private Placement and Debt Settlement Transactions; Grants Stock Options. Jan 27, 2020 822
UrbanGold Announces Stock Option Grant. Jan 21, 2020 462
Greenstar Biosciences Announces Grant of Stock Options. Jan 18, 2020 643
Geron awards inducement grants to two new employees under Nasdaq Listing Rule 5635(c)(4). Awards list Jan 17, 2020 200
MedX Health Corp announces grant of stock options at USD0.17 per share. Jan 17, 2020 174
ALX Resources Corp. Announces Grant of Stock Options. Jan 17, 2020 436
Kesselrun Resources Grants Stock Options. Jan 16, 2020 470
Elixxer Ltd. Grants Stock Options. Jan 16, 2020 297
East West Petroleum Grants Stock Options. Jan 16, 2020 267
BIGG Digital Assets Inc. Provides Update on Certified Cryptocurrency Investigator Designation and Grants Stock Options. Jan 14, 2020 1369
AVROBIO grants stock option to new employee. Jan 10, 2020 191
Senseonics grants stock options to five new non-executive employees under inducement plan. Jan 6, 2020 183
Akebia Therapeutics announces new employee stock options 113,450 common stock under Nasdaq Listing Rule 5635(c)(4). Jan 6, 2020 185
Wilton Resources Inc. Announces Grant of Stock Options. Jan 6, 2020 217
Datametrex Announces Grant of Stock Options. Jan 3, 2020 445
Sugarbud Announces Option Grant. Jan 2, 2020 322
TEI Comments on Proposed Changes to Canadian Tax Treatment of Employee Stock Options. Jan 1, 2020 2440
Marksmen Announces Granting of Stock Options. Dec 31, 2019 355
Seahawk Ventures Inc. Completes First Tranche of Financing and Grants Stock Options. Dec 30, 2019 539
Palladium One Grants Incentive Stock Options. Dec 29, 2019 794
Goldsource Announces Grant of Stock Options. Dec 24, 2019 337
Kala Pharmaceuticals awards stock options for 8,000 common shares under NASDAQ Listing Rule 5635(c)(4). Awards list Dec 20, 2019 173
Pulse Biosciences announces stock options to new employee at an exercise price of USD14.22 per share. Dec 17, 2019 170
Pulse Biosciences announces stock options to new employee at an exercise price of USD14.22 per share. Dec 17, 2019 166
Pearl River Announces Grant of Stock Options. Dec 17, 2019 566
NA Proactive news snapshot: Aftermath Silver, Gevo Inc, Heritage Cannabis, Humanigen, Newgioco, UPDATE ... Dec 12, 2019 1664
Akebia Therapeutics announces grant of stock options to 14 new employees pursuant to Nasdaq Listing Rule 5635(c)(4). Dec 4, 2019 202
Sage grants stock options and performance restricted stock units under NASDAQ Listing Rule 5635(c)(4). Dec 4, 2019 235
Akebia Therapeutics announces grant of stock options to 14 new employees pursuant to Nasdaq Listing Rule 5635(c)(4). Dec 4, 2019 198
Sage grants stock options and performance restricted stock units under NASDAQ Listing Rule 5635(c)(4). Dec 4, 2019 231
CGX Energy Announces Stock Option Grant. Dec 3, 2019 552
Plymouth Rock Technologies Inc. Announces Board Appoinment & Grants Incentive Stock Options. Nov 29, 2019 872
GOLO Mobile Inc. Announces Stock Option Grant. Nov 28, 2019 382
X4 Pharmaceuticals grants stock options at exercise price of USD11.03 per share. Nov 27, 2019 171
X4 Pharmaceuticals grants stock options at exercise price of USD11.03 per share. Nov 27, 2019 167
Scanfil Plc announces grant of stock options to CEO and members of the Management Group. Nov 27, 2019 353
Scanfil Plc announces grant of stock options to CEO and members of the Management Group. Nov 27, 2019 354
Omni-Lite Industries Announces Option Grant. Nov 25, 2019 640
Green Rise Capital Corporation Announces Stock Option Grant. Nov 25, 2019 486
Gossan Resources Provides Corporate Update and Grant of Stock Options. Nov 19, 2019 557
Ucore Grants Incentive Stock Options. Nov 15, 2019 379
Pacific Iron Ore Provides Corporate Updates. Nov 13, 2019 485
Delta 9 Reports Financials for Q3 2019 and Announces Grant of Stock Options. Nov 13, 2019 3837
Pine Cliff Energy Ltd. Grants Stock Options. Nov 8, 2019 262
TransCanna Grants Options. Nov 7, 2019 335
Sage Therapeutics awards stock options & PSUs under NASDAQ Listing Rule 5635(c)(4). Awards list Nov 6, 2019 218
Bear Creek Grants Incentive Stock Options. Nov 6, 2019 252
Media Central Corporation Inc. Private Placement and Stock Options Grant. Oct 30, 2019 712
Pacific Booker Minerals Inc. Announces Options Granted. Oct 30, 2019 324
NA Proactive news snapshot: Cloud Nine Education, Gold Resource Corp, Nano One Materials UPDATE ... Oct 29, 2019 1637
PTC Therapeutics awards stock options at exercise price of USD36.28 per share. Oct 24, 2019 210
Blue Star Grants Stock Options. Oct 22, 2019 837
Sixty North Gold Enters into Amending Agreement with New Discovery Mines Ltd., an IR Consulting Agreement, Grants Stock Options, and Settles Debt with Director for Consulting Fees. Oct 21, 2019 841
Pulse Biosciences announces grant of stock options to three new non-executive employees. Oct 16, 2019 199
Luminex Announces Granting of Options. Oct 16, 2019 701
C21 Announces Stock Option Grant. Oct 10, 2019 437
Amarc grants incentive stock options to director. Oct 9, 2019 119
Amarc grants incentive stock options to director. Oct 9, 2019 117
MediaValet Announces Grant of Options. Oct 9, 2019 411
Audentes Therapeutics grants stock options & RSUs to 21 new individuals under Nasdaq Listing Rule 5635(c)(4). Oct 7, 2019 291
Verastem Oncology grants stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4). Oct 7, 2019 234
Audentes Therapeutics grants stock options & RSUs to 21 new individuals under Nasdaq Listing Rule 5635(c)(4). Oct 7, 2019 287
Verastem Oncology grants stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4). Oct 7, 2019 230
Sage Therapeutics reports grant of stock options & PSUs pursuant to NASDAQ Listing Rule 5635(c)(4). Oct 3, 2019 207
Akebia Therapeutics grants stock options at exercise price of USD3.92 per share under Nasdaq Listing Rule 5635(c)(4). Oct 3, 2019 184
TILT Holdings reports forfeiture of 60m stock options. Oct 3, 2019 204
Desert Gold Grants Incentive Stock Options. Oct 3, 2019 606
Patagonia Gold S.A (LON: PGD)--Patagonia Gold Corp. Grants Incentive Stock Options--26/9/2019. Oct 3, 2019 225
Dicerna announces stock options at exercise price per share of USD14.00 under NASDAQ Listing Rule 5635(c)(4). Oct 2, 2019 183
Pacific Empire Minerals Announces Grant of Options. Oct 1, 2019 686
Giga Metals Grants Stock Options. Sep 26, 2019 188
Royal Road Minerals Announces Management Change and Incentive Stock Option Grant. Sep 23, 2019 768
Kala Pharmaceuticals grants stock option at exercise price of USD4.41 per share. Sep 20, 2019 179
American Creek Announces Issuance of First Installment of Shares to Agoracom Under Shares for Services Agreement and Grants Incentive Options. Sep 6, 2019 595
Protagonist Therapeutics grants stock options to two new employees. Sep 5, 2019 193
SilverCrest Announces Stock Option Grants. Sep 5, 2019 361
Benchmark Grants Stock Options. Sep 3, 2019 1062
Ninth Circuit overturns Tax Court's invalidation of transfer-pricing regs: Stock-based compensation is held includible in a cost-sharing agreement. Pirrone, Maria M. Sep 1, 2019 782
Bioasis Technologies announces grant of stock options to directors. Aug 30, 2019 124
Macro Enterprises Inc. Announces Grant of Stock Options. Aug 28, 2019 387
GoviEx grants stock options. Aug 26, 2019 275
Kaizen Discovery grants stock options. Aug 26, 2019 250
Falcon Grants Options. Aug 23, 2019 319
Body and Mind Grants Stock Options. Aug 23, 2019 1019
Cordoba Grants Stock Options. Aug 22, 2019 299
Avino grants restricted share units and stock options to directors, officers, employees and consultants. Aug 22, 2019 196
Jaguar Announces Grant of Options. Aug 22, 2019 205
American Creek Resources Grants Incentive Options. Aug 20, 2019 444
Pulse Biosciences' board announces stock options to six new employees under Nasdaq Marketplace Rule 5635(c)(4). Aug 19, 2019 185
Wildsky Resources Inc. Announces Stock Option Grant. Aug 15, 2019 556
Shoal Point announces options. Aug 15, 2019 166
Shanghai plans to grant foreign employees rights to receive A-shares as stock options. Aug 14, 2019 237
AVROBIO reports non-statutory stock options to two new employees under Nasdaq Listing Rule 5635(c)(4). Aug 13, 2019 212
Cuda Oil and Gas Inc. Announces Stock Option Grants and Share Issuance to Debenture Holder. Aug 7, 2019 670
Puma Biotechnology grants stock options to seven new employees under Nasdaq Listing Rule 5635(c)(4). Aug 7, 2019 192
Puma Biotechnology grants stock options to seven new employees under Nasdaq Listing Rule 5635(c)(4). Aug 7, 2019 188
Santacruz Silver Grants Stock Options - Clarification. Correction notice Aug 7, 2019 288

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |